FDA Announces Various Initiatives to Increase Oversight of the Dietary Supplement Industry

By Riëtte van Laack — On February 11, 2019, Dr. Gottlieb issued a statement that appears to build on statements from December 2018.   In December 2018, as part of remarks to the FDLI Enforcement, Litigation, and Compliance Conference, Dr. Gottlieb had alluded to FDA’s plans to step up its efforts regarding dietary supplement safety and deceptive claims.  Dr. Gottlieb expressed concern that the industry had grown and outpaced the Agency’s capacity to manage new risks.  As a first step, he had created a Dietary Supplement Working Group at the FDA, “comprised of representatives from multiple centers and offices across the agency” tasked to take “a hard look at what more the FDA can be doing within our existing authorities, including re-examining our own internal operating structure and procedures – and what new authorities might make sense.” The February 11 statement provides additional details.  As…

Read more detail on Recent Products Liability posts –

This entry was posted in Products Liability and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply